Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK

被引：0
|
作者：
Johnston, K. [1 ]
Powell, L. [1 ]
Popoff, E. [1 ]
L'Italien, G. [2 ]
Pawinski, R. [3 ]
Ahern, A. [3 ]
Large, S. [3 ]
Tran, T. [4 ]
Jenkins, A. [3 ]
机构：
[1] Broadst Hlth Econ & Outcomes Res, Vancouver, BC, Canada
[2] Biohaven Pharmaceut Inc, New Haven, CT USA
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Canada, Kirkland, PQ, Canada
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P038
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness of migraine prevention: The case of topiramate in the UK
    Brown, J. S.
    Papadopoulos, G.
    Neumann, P. J.
    Price, M.
    Friedman, M.
    Menzin, J.
    CEPHALALGIA, 2006, 26 (12) : 1473 - 1482
  • [22] Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model
    Ryan Thaliffdeen
    Anthony Yu
    Karen Rascati
    Clinical Drug Investigation, 2024, 44 : 209 - 217
  • [23] Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model
    Thaliffdeen, Ryan
    Yu, Anthony
    Rascati, Karen
    CLINICAL DRUG INVESTIGATION, 2024, 44 (03) : 209 - 217
  • [24] A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy
    Wolters, Sharon
    Carpay, Johannes A.
    Pronk, Marja H.
    Zuurbier, Karin W. M.
    Driessen, Maurice T.
    Lyras, Leonidas
    Postma, Maarten J.
    BMC NEUROLOGY, 2024, 24 (01)
  • [25] THE COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE COMPARED WITH WARFARIN IN THE TREATMENT AND SECONDARY PREVENTION OF ACUTE VENOUS THROMBOEMBOLISM IN THE UK
    Jugrin, A., V
    Ustyugova, A., V
    Urbich, M.
    Lamotte, M.
    Sunderland, T. J.
    VALUE IN HEALTH, 2014, 17 (07) : A489 - A489
  • [26] Costs of Psychotic Disorders and Cost-effectiveness of Cognitive Behavioural Therapy Compared to Supportive Treatment
    Konnopka, Alexander
    Stuhldreher, Nina
    Klingberg, Stefan
    Wittorf, Andreas
    Bechdolf, Andreas
    Mueller, Bernhard
    Wagner, Michael
    Wiedemann, Georg
    Woelwer, Wolfgang
    Sartory, Gudrun
    Koenig, Hans-Helmut
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2013, 16 : S19 - S19
  • [27] COST-EFFECTIVENESS OF OCTREOTIDE COMPARED WITH USUAL SUPPORTIVE THERAPY FOR THE TREATMENT OF NEUROENDOCRINE TUMORS IN COLOMBIA
    Ruiz, A.
    Alfonso-Cristancho, R.
    Mejia, A.
    Gonzalez, D.
    Maestre, K.
    Herran, S.
    VALUE IN HEALTH, 2011, 14 (07) : A543 - A543
  • [28] Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
    Xie, Qian
    Zheng, Hanrui
    Chen, Ye
    Peng, Xingchen
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [29] COST-EFFECTIVENESS OF HOME HOSPICE PALLIATIVE AND SUPPORTIVE CARE
    HILL, LT
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (01) : 63 - 64
  • [30] The cost-effectiveness of supportive periodontal care: a global perspective
    Pennington, Mark
    Heasman, Peter
    Gaunt, Francesca
    Guentsch, Arndt
    Ivanovski, Saso
    Imazato, Satoshi
    Rajapakse, Sunethra
    Allen, Edith
    Flemmig, Thomas
    Sanz, Mariano
    Vernazza, Chris
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2011, 38 (06) : 553 - 561
12345